{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"pinealon-glp1-gut","urls":{"read":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/pinealon-glp1-gut/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"pinealon-glp1-gut","title":"Pinealon for GLP-1 Agonist Gut Damage: Neural Repair Angle and Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:40:52.869Z","body_excerpt":"## What's breaking down if you have GLP-1 gut damage / gastroparesis\n\nGLP-1 receptor agonists slow gastric emptying as a core part of their action. This creates prolonged fullness and better glucose control but can lead to symptoms like nausea, bloating, vomiting, and in some cases diagnosed gastroparesis with stomach paralysis. The drug class acts on GLP-1 receptors in the stomach and enteric nervous system to inhibit motility. Over time this intended suppression can contribute to nerve and muscle changes in the gut wall in susceptible people. The condition involves both mechanical slowing and potential downstream effects on the gut-brain axis and circadian regulation of digestion.\n\nRepair pathways focus on restoring normal motility signaling and protecting enteric neurons rather than further suppressing signals. Pinealon is discussed in this context because its studied effects center on neural and pineal regulation, which may intersect with gut motility control via melatonin and circadian pathways.\n\n## Why Pinealon might help you\n\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\n2. Therefore for you: If the neural / pineal layer is part of your problem, Pinealon is discussed because it targets repair (tissue) — not because it masks pain.\n\nPinealon is a tripeptide (Glu-Asp-Arg) studied for effects on gene expression in neurons and pineal gland function. If your gut slowing involves disrupted enteric nervous system signaling or circadian misalignment of motility (common with chronic GLP-1 use), the peptide's reported actions on reducing oxidative stress in neural cells and supporting pineal output could theoretically aid recovery of normal rhythm and motility control. Animal data show it limits reactive oxygen species in cerebellar cells and improves cognitive outcomes after prenatal stress. Small human observations link it to better attention, memory, and sleep architecture. No studies test it directly against GLP-1-induced gastroparesis, so any link remains mechanistic and speculative.\n\n## Why GLP-1 agonists (class) matters for you\n\n1. Drug: GLP-1 agonists (class)\n2. What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\n3. Therefore for you: This drug suppresses a motility signal to support metabolism and satiety; the tradeoff is potential persistent gut slowing that may outrun natural repair in some users.\n\nGLP-1 agonists deliver clear metabolic gains but intentionally reduce gastric emptying. When this effect becomes excessive it trades short-term appetite control for longer-term motility challenges. Repair-focused approaches would aim to restore normal enteric function once the drug load is adjusted, rather than adding more suppression.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- Pinealon → neural / pineal\n\nPinealon addresses the neural/pineal layer that may influence gut motility through circadian and melatonin-related pathways. GLP-1 agonists primarily suppress motility signals for metabolic effect. The combination framing highlights one supporting repair at the neural level while the other manages the metabolic driver, without overlap in mechanism.\n\n## What the evidence actually shows\n\nPinealon human data: Small Russian trials report cognitive improvements (attention, memory) and reduced anxiety in elderly or stressed subjects. One trial noted better performance in traumatic brain injury patients. No human trials examine Pinealon for any gastrointestinal condition or GLP-1 side effects. Preclinical: Rat and cell studies show reduced oxidative stress, normalized MAPK signaling, and neuroprotection. Animal work does not include gut motility models for this peptide.\n\nGLP-1 gastroparesis data: Multiple clinical reports and reviews document delayed gastric emptying as the intended mechanism; incid","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c1","text":"GLP-1 agonists slow gastric emptying as intended mechanism, sometimes leading to gastroparesis symptoms.","tier":"human","weight":0.8,"section":"What's breaking down if you have GLP-1 gut damage / gastroparesis","slot":null,"interaction_risk":false,"status":"active","source_ids":["s20","s28"],"source_status":"sourced","why_material":"Establishes the core tradeoff for the reader condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"Pinealon is a tripeptide studied primarily for neuroprotective and cognitive effects in small human trials and animal models.","tier":"human","weight":0.8,"section":"Why Pinealon might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0"],"source_status":"sourced","why_material":"Grounds the neural/pineal layer focus.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c3","text":"No human or animal studies test Pinealon for gastrointestinal motility, gastroparesis, or GLP-1 side effects.","tier":"human","weight":0.8,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0"],"source_status":"sourced","why_material":"Highlights evidence gap for this specific cross.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c4","text":"Gut melatonin levels exceed pineal production and modulate intestinal motility via MT receptors.","tier":"preclinical","weight":0.5,"section":"Why Pinealon might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s36"],"source_status":"sourced","why_material":"Provides indirect mechanistic bridge to neural/pineal effects.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false}],"sources":[{"id":"s0","type":"other","url":"https://superpower.com/guides/pinealon","title":"Pinealon (EDR): A Khavinson-Group Tripeptide in ...","quote":"No Phase 1 safety study of Pinealon in humans has been published in indexed, English-language peer-reviewed literature.","summary":"Review of Pinealon evidence notes limited published human safety data.","claim_ids":["c2","c3"],"link_status":"ok","quote_status":"verified","hash":"e578a2427889790b35752f308508bd8092a235a0faf6a850c8e43048b9e1cfe6"},{"id":"s20","type":"review","url":"https://tech.snmjournals.org/content/52/1/3","title":"Glucagonlike Peptide-1 Receptor Agonists","quote":"The Food and Drug Administration has recently received reports of stomach paralysis, or severe gastroparesis, developing with the antiobesity ...","summary":"Discusses GLP-1 gastroparesis reports.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"996be5a21f14ce45fdfd76fe1743137a8b2922739abfc50037b13df36a2c32dd"},{"id":"s28","type":"news","url":"https://www.webmd.com/obesity/ozempic-and-stomach-paralysis","title":"Ozempic Stomach Paralysis","quote":"According to new research, as many as 1 in 20 new users of GLP-1s who are obese or have diabetes go on to develop stomach paralysis.","summary":"Reports incidence estimates for GLP-1 gastroparesis.","claim_ids":["c1"],"link_status":"ok","quote_status":"verified","hash":"fefa2cc626a39421e8294bb4db8cd2195a347cf82ebd04aa60f78ccf7268449f"},{"id":"s36","type":"review","url":"https://amjcaserep.com/abstract/full/idArt/951067","title":"Therapeutic Use of Melatonin for Gastrointestinal Motility and ...","quote":"melatonin modulates GI smooth-muscle activity, enteric nervous system signaling, and motility patterns through MT1 and MT2 receptors","summary":"Links gut melatonin to motility regulation.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"a6aa0fcc5475d19da6f4d82732cddb573717546220cad04a22d2e8fac6205295"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s20","type":"review","url":"https://tech.snmjournals.org/content/52/1/3","title":"Glucagonlike Peptide-1 Receptor Agonists","quote":"The Food and Drug Administration has recently received reports of stomach paralysis, or severe gastroparesis, developing with the antiobesity ...","summary":"Discusses GLP-1 gastroparesis reports.","claim_ids":["c1"],"link_status":"http_403","quote_status":"unverified","hash":"996be5a21f14ce45fdfd76fe1743137a8b2922739abfc50037b13df36a2c32dd"},{"id":"s36","type":"review","url":"https://amjcaserep.com/abstract/full/idArt/951067","title":"Therapeutic Use of Melatonin for Gastrointestinal Motility and ...","quote":"melatonin modulates GI smooth-muscle activity, enteric nervous system signaling, and motility patterns through MT1 and MT2 receptors","summary":"Links gut melatonin to motility regulation.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"a6aa0fcc5475d19da6f4d82732cddb573717546220cad04a22d2e8fac6205295"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"pinealon-glp1-gut","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":4,"anecdotal":0,"scientific":2,"user_reports":0,"questions":0,"evidence_ingests":0}}